Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201305047 Principal Investigator: Bartlett, Nancy
Title: A phase 2 study of brentuximab vedotin in combination with standard of care treatment (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (RCHOP) as front-line therapy in patients with diffuse large B-cell lymphoma (DLBCL)
Phase: II Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study is being done to test the safety and effectiveness of 2 different doses of brentuximab vedotin when given with a combination of drugs called RCHOP [rituximab, cyclophosphamide, hydroxydaunorubicin (also called doxorubicin),
vincristine (Oncovin), and prednisone].
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)